EU Slaps Massive Tariffs on Boeing Jets—Trump-Era Trade War Flares Again
The European Union just fired a $4 billion warning shot across Boeing’s bow—because nothing says ’diplomacy’ like punitive trade measures dressed up as policy.
Subheader: Trade Tensions Take Off
Brussels isn’t subtle: these tariffs are pure retaliation for Trump’s earlier Airbus penalties. Because when giants clash, it’s always the supply chains—and shareholders—that get trampled.
Subheader: The Finance Angle (Because Someone’s Paying)
Boeing’s stock dipped on the news—shocking, we know—while EU manufacturers quietly high-fived. Another day, another zero-sum game where ’winning’ just means losing slower.
Closer: Grab your popcorn. This trade war’s cruising altitude? Nowhere near its ceiling.
Trump’s April tariffs put Boeing in Europe’s crosshairs
Trump introduced the latest round of tariffs on April 2, placing a 20% charge on almost all goods coming from the EU. He adjusted the rate on April 9, reducing it to 10% for 90 days to give negotiators time to progress. But the White House left other tariffs untouched, including the 25% tax on European steel, cars, and aluminum, which are still active.
Brussels made a calculated decision to pause retaliatory tariffs on €21 billion worth of American products until July 14, hoping to give diplomacy a chance.
The list included Harley-Davidson motorcycles, chicken meat, and textile imports. But officials warned that a fresh batch of penalties—now including Boeing jets and potentially chemical products—will roll out right after the pause ends unless a deal is reached before then.
The European pharmaceutical sector also got a direct warning this week. On Monday, Trump announced that his administration would impose new duties on drug exports from Europe in the next two weeks.
While most pharma stocks fell on the news, Novo Nordisk, a major Danish company, reported better-than-expected earnings and saw its shares jump by 4.4%. Still, the firm lowered its 2025 outlook, citing weaker demand for its weight-loss drug Wegovy.
The Stoxx 600, Europe’s main stock index, was down 0.67% by mid-afternoon in London. The retail sector dropped 2.3%, leading the losses across the board.
Investors are still watching key earnings reports from companies like BMW, Legrand, Ørsted, Pandora, Veolia, Fresenius, Siemens Healthineers, Skanska B, JD Wetherspoon, Vonovia, Delhaize, and Telecom Italia.
Cryptopolitan Academy: Coming Soon - A New Way to Earn Passive Income with DeFi in 2025. Learn More